DDW Highlights: 24 October 2022

<p><span data-contrast="auto">The latest episode of the</span> <a href= "https://www.ddw-online.com/t/ddw-highlights-podcast/"><span data-contrast="none"> DDW Highlights</span> <span data-contrast="none">podcast</span></a> <span data-contrast="auto">is now available for download. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.</span><span data-ccp-props= "{"201341983":0,"335559739":160,"335559740":259}"> </span></p> <p><span data-contrast="auto">This round-up was compiled by DDW’s Diana Spencer.</span> Amid continued concern about antibiotic resistance, the headline news this week was the discovery of a new antibiotic that could be effective against some of the most treatment-resistant pathogens. However, there was also controversy as researchers faced a backlash from the National Institute of Allergy and Infectious Diseases for their study which created a hybrid version of Covid-19. </p>